ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the Canadian launch of its Trifecta™ aortic stented tissue valve. The first procedures in Canada were performed by Dr. Anson Cheung, Surgical Director of Cardiac Transplantation for Providence Health Care.
